Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FE0GA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 16, 2025, by the Defense Logistics Agency (DLA) for Stelara 90 mg/mL syringes, valued at $16,249.95. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which is valued at $500 million and extends through November 2026. The delivery order carries no set-aside designation and has an ultimate completion date of October 7, 2025, with performance taking place at the contractor's Park Ridge, Illinois facility.
Stelara is a biologic immunosuppressant medication commonly used in military and federal healthcare settings to treat conditions such as plaque psoriasis, psoriatic arthritis, and inflammatory bowel disease. This award reflects DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, providing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's comprehensive IDC portfolio with the DLA enables efficient procurement of a wide range of pharmaceutical products to support medical supply needs across military health facilities.
Quick answers
Who was awarded contract SPE2DB25FE0GA?
SPE2DB25FE0GA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FE0GA worth?
The government has obligated $16,250 on SPE2DB25FE0GA.
Is contract SPE2DB25FE0GA an order under another contract?
Yes. SPE2DB25FE0GA is a delivery order under SPE2DB22D9130, an indefinite delivery contract.
Was contract SPE2DB25FE0GA competed?
The extent of competition for SPE2DB25FE0GA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award